196 Programs
-
Year in Review
Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Localized HR-Positive Breast Cancer
-
-
H
-
J
-
H
-
-
H
-
J
-
H
+1 more module
-
-
ASCO Satellite 2026
Second Opinion: Investigators Provide Perspectives on the Current and Future Use of Novel Therapies for Non-Hodgkin Lymphoma
-
-
B
-
C
-
M
- +1
-
B
-
-
ASCO Satellite 2026
What Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Current and Future Role of Antibody-Drug Conjugates in the Management of Breast Cancer
-
-
E
-
H
-
N
- +2
-
E
-